Literature DB >> 25504220

Role of the endothelium in the metabolic syndrome: IIB or not IIB.

Philip W Shaul1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25504220      PMCID： PMC4419335          DOI： 10.1097/MAJ.0000000000000402

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  10 in total

1.  C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Authors:  Keiji Tanigaki; Chieko Mineo; Ivan S Yuhanna; Ken L Chambliss; Michael J Quon; Ezio Bonvini; Philip W Shaul
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

2.  Intra-abdominal adiposity and individual components of the metabolic syndrome in adolescence: sex differences and underlying mechanisms.

Authors:  Catriona Syme; Michal Abrahamowicz; Gabriel T Leonard; Michel Perron; Alain Pitiot; Xi Qiu; Louis Richer; John Totman; Suzanne Veillette; Yongling Xiao; Daniel Gaudet; Tomas Paus; Zdenka Pausova
Journal:  Arch Pediatr Adolesc Med       Date:  2008-05

Review 3.  Regulation of endothelial nitric oxide synthase: location, location, location.

Authors:  Philip W Shaul
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

4.  Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.

Authors:  P W Shaul; E J Smart; L J Robinson; Z German; I S Yuhanna; Y Ying; R G Anderson; T Michel
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase.

Authors:  Chieko Mineo; Andrew K Gormley; Ivan S Yuhanna; Sherri Osborne-Lawrence; Linda L Gibson; Lisa Hahner; Ralph V Shohet; Steven Black; Jane E Salmon; David Samols; David R Karp; Gail D Thomas; Philip W Shaul
Journal:  Circ Res       Date:  2005-11-03       Impact factor: 17.367

6.  Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ivan Yuhanna; Philip Shaul; Ishwarlal Jialal
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

7.  Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children.

Authors:  Claudia M Toledo-Corral; Emily E Ventura; Howard N Hodis; Marc J Weigensberg; Christianne J Lane; Yanjie Li; Michael I Goran
Journal:  Atherosclerosis       Date:  2009-03-25       Impact factor: 5.162

8.  C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.

Authors:  Wanpen Vongpatanasin; Gail D Thomas; Randall Schwartz; Lisa A Cassis; Sherri Osborne-Lawrence; Lisa Hahner; Linda L Gibson; Steven Black; David Samols; Philip W Shaul
Journal:  Circulation       Date:  2007-02-05       Impact factor: 29.690

9.  C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice.

Authors:  Randall Schwartz; Sherri Osborne-Lawrence; Lisa Hahner; Linda L Gibson; Andrew K Gormley; Wanpen Vongpatanasin; Weifei Zhu; R Ann Word; Divya Seetharam; Steven Black; David Samols; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2007-04-19       Impact factor: 17.367

10.  C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery.

Authors:  Keiji Tanigaki; Wanpen Vongpatanasin; Jose A Barrera; Dmitriy N Atochin; Paul L Huang; Ezio Bonvini; Philip W Shaul; Chieko Mineo
Journal:  Diabetes       Date:  2012-10-15       Impact factor: 9.461
  10 in total
  1 in total

1.  Effect of baicalin on gestational hypertension-induced vascular endothelial cell damage.

Authors:  Yang Liu; Miao Xiong; Fangfang Zhou; Nana Shi; Yunbin Jia
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.